122 related articles for article (PubMed ID: 10763152)
1. Blood-borne cancer cells--quo vadis?
Brandt B; Schmitt H; Feldner JC; Lellé RJ; Semjonow A; Beckmann A
Int J Biol Markers; 2000; 15(1):111-3. PubMed ID: 10763152
[TBL] [Abstract][Full Text] [Related]
2. Predictive laboratory diagnostics in oncology utilizing blood-borne cancer cells--current best practice and unmet needs.
Brandt BH; Schmidt H; de Angelis G; Zänker KS
Cancer Lett; 2001 Jan; 162 Suppl():S11-S16. PubMed ID: 11164185
[TBL] [Abstract][Full Text] [Related]
3. Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients.
Brandt B; Roetger A; Heidl S; Jackisch C; Lelle RJ; Assmann G; Zänker KS
Int J Cancer; 1998 Jun; 76(6):824-8. PubMed ID: 9626348
[TBL] [Abstract][Full Text] [Related]
4. Frequent detection and immunophenotyping of prostate-derived cell clusters in the peripheral blood of prostate cancer patients.
Schmidt H; De Angelis G; Bettendorf O; Eltze E; Semjonow A; Knichwitz G; Brandt B
Int J Biol Markers; 2004; 19(2):93-9. PubMed ID: 15255540
[TBL] [Abstract][Full Text] [Related]
5. Isolation of prostate-derived single cells and cell clusters from human peripheral blood.
Brandt B; Junker R; Griwatz C; Heidl S; Brinkmann O; Semjonow A; Assmann G; Zänker KS
Cancer Res; 1996 Oct; 56(20):4556-61. PubMed ID: 8840959
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques.
Ring AE; Zabaglo L; Ormerod MG; Smith IE; Dowsett M
Br J Cancer; 2005 Mar; 92(5):906-12. PubMed ID: 15714202
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients.
Molnar B; Ladanyi A; Tanko L; Sréter L; Tulassay Z
Clin Cancer Res; 2001 Dec; 7(12):4080-5. PubMed ID: 11751505
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of carcinoma cells in the blood.
Racila E; Euhus D; Weiss AJ; Rao C; McConnell J; Terstappen LW; Uhr JW
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4589-94. PubMed ID: 9539782
[TBL] [Abstract][Full Text] [Related]
10. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
[TBL] [Abstract][Full Text] [Related]
11. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
[TBL] [Abstract][Full Text] [Related]
12. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratins and tissue polypeptide antigen.
Sundström BE; Stigbrand TI
Int J Biol Markers; 1994; 9(2):102-8. PubMed ID: 7523541
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
[TBL] [Abstract][Full Text] [Related]
16. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
[TBL] [Abstract][Full Text] [Related]
17. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 19 expression by reverse transcriptase-polymerase chain reaction in the peripheral blood of prostate cancer patients.
Tobias-Machado M; Fonseca F; Fantinato AP; Bendit I; Wroclawski ML; Wroclawski E; del Giglio A
Tumori; 2005; 91(3):248-52. PubMed ID: 16206649
[TBL] [Abstract][Full Text] [Related]
19. Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer.
Marrakchi R; Ouerhani S; Benammar S; Rouissi K; Bouhaha R; Bougatef K; Messai Y; Khadimallah I; Rahal K; Ben Ammar-Elgaaied A
Int J Biol Markers; 2008; 23(4):238-43. PubMed ID: 19199272
[TBL] [Abstract][Full Text] [Related]
20. Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells.
Zabaglo L; Ormerod MG; Parton M; Ring A; Smith IE; Dowsett M
Cytometry A; 2003 Oct; 55(2):102-8. PubMed ID: 14505315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
